FDA Inspection 1257639 — MAK PHARMA USA LLC

MAK PHARMA USA LLC — FEI 3017721405

The FDA completed an inspection of MAK PHARMA USA LLC on Dec 30, 2024 in Randolph, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 30, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Randolph, NJ (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.